Erythematous skin lesions due to infection with Borrelia burgdorferi will often disappear without antibiotic treatment. The aim of the study was to assess whether after disappearance of the erythematous skin lesion B.
Lyme borreliosis (LB) is a tick-borne disease caused by Borrelia burgdorferi (33) . Erythema migrans (EM) is the early characteristic sign of local skin infection due to B. burgdorferi. In patients treated with an appropriate antibiotic, EM resolves within some days. Without antibiotic treatment, EM lesions fade away with time in most cases but disseminated infection may develop within weeks to months, leading to nervous system, musculoskeletal, and cardiac involvement (33) . Approximately 50% of the patients with early disseminated LB have a history consistent with EM preceding the onset of disseminated disease (3, 14, 26, 34) . B. burgdorferi is present in the EM lesions. Culturing of skin biopsy specimens taken from the margin of EM lesions showed recovery of B. burgdorferi in 57 to 86% of patients (7, 21, 31) . Whether disappearance of EM in patients not treated with an antibiotic coincides with the disappearance of B. burgdorferi from the skin is generally unknown. Clinically, the development of acrodermatitis chronica atrophicans as a late manifestation of LB suggests that after EM has faded away B. burgdorferi can persist in healthy skin with a healthy appearance. Asbrink et al. reported that approximately 20% of the patients with acrodermatitis chronica atrophicans had a history consistent with EM; these EM lesions had always been located at the same extremity where acrodermatitis chronica atrophicans had developed after months to years (2) . In vitro, it has been shown that B. burgdorferi can invade fibroblasts, possibly leading to long-term persistence of spirochetes within these cells (16) .
The aim of this study was to examine whether B. burgdorferi is still present in the healthy-looking skin of patients presented after disappearance of a skin lesion who have not been treated with antibiotics. Skin biopsy specimens from the site of previous lesions were taken from seven patients. B. burgdorferi was cultured from six patients 1 to 6 months after their EM lesions had faded away and from one patient 2 months after a tick bite which was not followed by the occurrence of EM.
MATERIALS AND METHODS
Patients. In total, seven patients were included in the study. None of the seven patients had been treated with antibiotics prior to referral to the hospital. From May 1989 through September 1992, five consecutive patients with early disseminated LB (1) without the presence of a skin lesion entered the study (Table 1 , patients 1 through 5). Four of them had histories of a previous erythematous skin lesion. The fifth patient recalled a tick bite without a subsequent rash. These five patients met the case definition for public health surveillance for LB of the Centers for Disease Control (9) . Two other patients consecutively referred to our hospital during the same period (Table 1 , patients 6 and 7) had histories of a previous erythematous skin lesion without obvious manifestations of early disseminated LB. From all patients, a skin biopsy specimen was taken. From four of these patients who had signs of neuroborreliosis (Table 1, patients 1 and 3 to 5) , a cerebrospinal fluid (CSF) sample was also cultured.
Sites and processing of skin biopsy specimens. Six patients recalled and indicated the sites of previous erythematous skin lesions. A skin biopsy specimen was taken from healthylooking skin at the site of the previous erythematous skin lesion in these patients (Table 1 , patients 1 to 4, 6, and 7). From one patient (patient 5) who recalled a tick bite but had not developed a skin lesion, the skin biopsy specimen was taken at the site where the tick had been attached, as remembered by the patient. From patient 7, an additional skin biopsy specimen was taken at a site where no previous skin lesion had been observed. A 4-mm-diameter biopsy was taken with a 716 KUIPER ET AL. 5 ,000 x g for 20 min. The pellet was transferred to 5.5 ml of modified Kelly's medium without antimicrobial agents. Incubation at 33°C was done for 8 weeks. The presence of spirochetes was determined by dark-field microscopy weekly. A culture was considered positive when motile spirochetes were seen. All isolates were preserved at -70°C with 50% glycerolpeptone for cryoprotection.
We used the culture method for skin biopsy specimens to culture B. burgdorferi from the periphery of EM lesions of 57 consecutive patients referred to our hospital. All these patients were examined by a dermatologist (Toni Ramselaar or Irina Cairo) and met the Centers for Disease Control case definition criteria for EM. The recovery rate of B. burgdorferi from skin biopsy specimens from patients with EM was 86% (36) .
Characterization of isolates. Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) was performed as described elsewhere (36) to evaluate differences between the isolates. Spirochetes were used after 3 to 13 passages in vitro. Briefly, spirochetes were grown in modified Kelly's medium until stationary phase was reached, harvested by centrifuging at 5,000 x g for 30 min, and washed three times with 50 mM Tris-HCl (pH 7.4). The pellet was resuspended in 5 ml of 50 mM Tris-HCl (pH 7.4), diluted 1:1 with SDS sample buffer (2% SDS, 5% ,-mercaptoethanol, and 10% glycerol in 0.125 mM Tris-HCl [pH 6.8]), and boiled for 5 min. Aliquots (30 ,ul) of diluted suspension were applied in each lane. SDS-PAGE was performed on 13% polyacrylamide gels 1.5 mm thick (17) . Silver staining of polyacrylamide gels was performed by the method of Morrissey (22) .
The genospecies of isolated spirochete strains was identified by rRNA gene restriction analysis as described elsewhere (5, 36) . In short, spirochetes were harvested from 100 ml of modified Kelly's medium. DNA was isolated as described by Wilson (37) . Six micrograms of isolated DNA was digested with Hindlll (Boehringer GmbH, Mannheim, Germany) overnight, separated on a 0.8% agarose gel and transferred to nitrocellulose by diffusion blotting. Blots were hybridized with 32P-labelled Escherichia coli rRNA (Boehringer GmbH) (12) .
Reference strains B31 (ATCC 35210), VS102, and VS461 for B. burgdorferi sensu stricto, Borrelia garinii, and group VS461, respectively, have been described elsewhere (5, 18) .
Genospecies-specific PCR (18) ies against B. burgdorferi were present in the sera of these five patients, all of them met the Centers for Disease Control criteria for LB. Three of the four patients with neuroborreliosis had also antibodies against B. burgdorferi in the CSF; one patient (patient 4), who only had immunoglobulin M (IgM) antibodies against B. burgdorferi in her serum, had no CSF antibodies against B. burgdorferi. Two other patients were included in the study, since they reported previous erythematous lesions and had antibodies against B. burgdorferi in their sera. One of them (patient 6) had mild myalgia at the time of skin biopsy, whereas the other patient (patient 7) was asymptomatic. The temporal relation between the clinical manifestations and the time that the skin biopsy specimens were taken is shown in Fig. 1 . The interval between the disappearance of the erythematous skin lesion or the occurrence of the tick bite and the collection of the skin biopsy specimens ranged from 1 (patient 2) to 6 (patient 7) months.
Skin biopsy specimens were taken from healthy-looking skin from all seven patients. The skin biopsy specimen was collected from the site of the previous primary erythematous lesion for five patients (patients 1, 3, 4, 6, and 7), of the previous secondary erythematous lesion for patient 2, and of the previous tick bite for patient 5. B. burgdorferi was cultured from skin biopsy specimens of all seven patients. None of the cultures became contaminated with other microorganisms. From patient 7, a culture from a second skin biopsy specimen taken at a site without a previous skin lesion remained negative.
By SDS-PAGE analysis, heterogeneity of the seven strains originating from skin biopsy specimens was shown. Four strains, from patients 1, 2, 4, and 6 (Fig. 2, lanes 4, 5, 7 , and 9) were characterized by an OspA protein and an OspB protein with molecular masses of 32 and 34 kDa, respectively. An additional 18-kDa protein was present in only two of these strains (Fig. 2, lanes 7 and 9) . The strains from patients 3 and 5 had OspA with a molecular mass of 32 kDa, and a second band, possibly OspB, located at 33 kDa and slightly above OspA (Fig. 2, lanes 6 and 8) presence of a 1.2-kb hybridizing band and the absence of 4.0-and 1.45-kb bands, a pattern reported to be specific for B. garinii (5), in the strains from patients 1 through 6 (Fig. 3, lanes  4 to 9) . The strain from patient 7 showed hybridizing bands at 4.0 and 1.45 kb but not at 1.2 kb, a pattein described for group VS461 strains (Fig. 3, lane 10) . In addition, a hybridizing band at 0.8 kb was noted in the strains from patients 1, 2, 4, 6, and 7 (marked with a star in Fig. 3, lanes 4, 5, 7, 9 , and 10). This band was not seen in the reference B. garinii strain (lane 2) but 1 2 3 4 5 6 7 8 9 65°C . Lanes 1 to 3: reference strains B31, VS102, and VS461 for B. burgdorferi sensu stricto, B. garinii, and group VS461, respectively. Lanes 4 to 10: strains A19S, A76S, A77S, A91S, A87S, A94S, and A84S, respectively. At the right, the positions of molecular mass markers (in kilobases) are shown. At the left, arrows indicate hybridizing bands specific for B. burgdorferi sensu stricto (I), B. garinii (II), and group VS461 (III). The star indicates the 0.8-kb band (not included in the analysis of earlier autoradiograms on which this band was hardly visible [36] ) seen in the reference strains for B. burgdorferi sensu stricto and group VS461 and the strains from patients 1, 2, 4, 6, and 7. FIG. 4. Genospecies-specific PCR for the three genospecies of B. burgdorferi sensu lato. Borrelial DNA was amplified by using specific primers for B. burgdorferi sensu stricto (A), B. garinii (B), and group VS461 (C) as described in Materials and Methods. Lanes 1 to 10 are as described for Fig. 3 . Lane 11 contains a 123-bp ladder as a molecular mass marker.
was visible in the reference strains for B. burgdorferi sensu stricto and group VS461 (lanes 1 and 3) . It was concluded that the strains from patients 4 and 6 were B. garinii and the strain from patient 7 was group VS461 and that an additional typing method was necessary for the other four strains. Therefore, isolates were also genotyped by genospecies-specific PCR (18) . Using the primer pair specific for B. garinii, a 527-bp fragment was amplified from the strains recovered from patients 1 through 6 (Fig. 4) . A 591-bp fragment was amplified from the isolate from patient 7 by the primer pair specific for group VS461. Therefore, we conclude that the strains from patients 1 through 6 were B. garinii and the strain from patient 7 belonged to group VS461.
B. burgdorferi was isolated from CSF samples from only two (patients 3 and 4) of the four patients with neuroborreliosis. By SDS-PAGE analysis, skin and CSF isolates from patient 3 were identical, whereas skin and CSF isolates of patient 4 differed only quantitatively with regard to OspC and a 19-kDa protein (not shown). rRNA gene restriction analysis and genospeciesspecific PCR of the CSF isolates showed that they were both B. garinii (not shown).
DISCUSSION
In this study, B. burgdorferi was cultured from skin biopsy specimens collected from healthy-looking skin of seven subjects. Specimens had been collected either at the site of a previous erythematous skin lesion or (7, 21, 31) . For cultures of body fluids from patients with early disseminated LB, the recovery rate of B. burgdorferi is much lower, ranging from 2 to 19% for blood (6, 24, 25, 29, 35) and from 11 to 20% for CSF (15, 29, 35 burgdorferi from the skin has been studied by culturing posttreatment skin biopsy specimens taken from healthy-looking skin from the site from which B. burgdorferi had been cultured before treatment (8, 23 ). In total, 26 patients were involved in these studies, and cultures were negative in all cases. However, B. burgdorferi has been cultured from skin biopsy specimens obtained at the sites of previous erythematous lesions from three patients after antibiotic therapy (27) . In vitro studies showed that human skin fibroblasts can protect B. burgdorferi from antibiotic treatment (11) .
Invasion of spirochetes into fibroblasts has been documented and could serve as a possible mechanism by which spirochetes can escape from antimicrobial actions of antibiotics (16 (36) .
After the LB diagnosis was made, the five patients with disseminated LB were treated with intravenous antibiotics and recovered completely. The other two patients, who had no clinically active LB, were given a short course of oral antibiotics and developed no signs of disseminated LB. We conclude that in patients suspected of having early disseminated LB, B. burgdorferi is frequently present at the site of the previous erythematous skin lesion. Since taking skin biopsy specimens is simple and harmless, with minimal discomfort for the patient, culturing of skin biopsy specimens provides an additional opportunity to obtain a definitive diagnosis for patients suspected of having early disseminated LB.
